Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030

Keywords

Parkinson's disease, Disease, Medicine, Demography, Geography

References

• Epidemiology of Parkinson's diseaseMeike Kasten, Annabel Chade, Caroline M. Tanner — 2007
• Major causes of death among men and women in China.Jiang He, Dongfeng Gu, Xigui Wu — 2005
• Cross‐sectional survey of Parkinson's disease and parkinsonism in a rural area of the United KingdomPeter Hobson, John Gallacher, Jolyon Meara — 2005
• Global prevalence of dementia: a Delphi consensus studyCleusa P. Ferri, Martin Prince, Carol Brayne — 2005
• Global health status: two steps forward, one step back.Gunnar Kvåle — 2000
• Methods for projecting the incidence and prevalence of chronic diseases in aging populations: application to Alzheimer's disease.Ron Brookmeyer, Sarah M. Gray — 2000
• EPIDEMIOLOGY OF PARKINSON'S DISEASECaroline M. Tanner, Samuel M. Goldman — 1996
• Prevalence of Parkinson disease in SingaporeLouis Tan, Narayanaswamy Venketasubramanian, Cassandra Hong — 2004
• Prevalence of Parkinson's disease in the L'Aquila district, central ItalyRocco Totaro, Corrado P. Marini, Francesca Pistoia — 2005
• The prevalence of PD in a nutritionally deficient rural population in ChinaL. Zhang, Ziyun Nie, Yang Liu — 2005
• [Epidemiology of Parkinson disease].Domínguez Carmona M — 1989

Cited by

• Managing Uncertainty in Young-Onset Parkinson's DiseaseMichael J. Ravenek — 2014
• Exposure Assessment of Pesticides and the Effect of Combinations of Pesticides on Parkinson's DiseaseAnthony Weirehn Wang — 2012
• Monozygotic female twins discordant for phenotype of Wilson's disease晴明 加藤, 伸悟 寺岡 — 2009
• Costs of Illness in a Russian Cohort of Patients with Parkinson’s DiseaseSebastián M. Llompart Moragues — 2012
• Clinical neuroprotection in Parkinson's disease - still waiting for the breakthrough.Thierry Ripoll, Jacques Vauclair — 2010
• Progression and prognostic factors of motor impairment, disability and quality of life in newly diagnosed Parkinson's diseaseJe G., Kyong Soo Park — 2011
• Untersuchung des Expressionsmusters und der Neuropathologie konditionaler Mausmodelle des Morbus ParkinsonSilke Nuber — 2008
• Antiparkinsonian activity of some 9-N-, O-, S- and C-derivatives of 3-methyl-6-(prop-1-en-2-yl)cyclohex-3-ene-1,2-diol.Bernabé Dalmau — 2013
• Protective Effects of SKF-96365, a Non-Specific Inhibitor of SOCE, against MPP+-Induced Cytotoxicity in PC12 Cells: Potential Role of Homer1Mauricio Fattore, Guiseppe Piromalli — 2013
• Lower plasma ApoA1 levels are found in Parkinson’s disease and associate with APOA1 genotypeRichard F. Muth — 2014
• The Utility of the Mini-Addenbrooke's Cognitive Examination as a Screen for Cognitive Impairment in Elderly Patients with Chronic Kidney Disease and DiabetesJohn Breuilly — 2016
• Longitudinal Changes in Speech Breathing in Older Adults with and without Parkinson’s DiseaseM. Thalal, Hiswanil — 2017
• 5-Substituted 2-benzylidene-1-tetralone analogues as A1 and/or A2A antagonists for the potential treatment of neurological conditions.雄二 加藤 — 2017
• 200 Years of Parkinson’s disease: what have we learnt from James Parkinson?正弘 岡田, 一樹 丹羽, 誠治 小瀬村 — 2018
• The association between HSD3B7 gene variant and Parkinson's disease in ethnic ChineseRicardo Devis Botella — 2018
• Identification of altered microRNAs in serum of a mouse model of Parkinson's disease.Червонюк Владимир Иванович — 2018
• Drug Repurposing in Parkinson’s Disease和俊 平田, 邦壽 武居 — 2018
• Development of Adenosine A2A Receptor Antagonists for the Treatment of Parkinson's Disease: A Recent Update and Challenge.Anders Lundholm — 2018
• The synthesis and evaluation of (E)-styrylisatin analogues as inhibitors of monoamine oxidase BVan der Walt, Elizna Magdalena — 2008
• The prevalence of Parkinson's disease continues to rise after 80 years of age: a cross-sectional study of Chinese veterans.Y-M Zou, J-P Tan, Nanxin Li — 2014

Related papers

• 薬剤性Parkinson症候群 (7月第1土曜特集 Parkinson病) -- (Parkinson症候群)茂樹 葛原 — 1998
• PET/SPECTによるParkinson病研究の進歩 (7月第1土曜特集 Parkinson病) -- (Parkinson病の分子病態)仁 篠遠, 寛 福田 — 1998
• The interaction axis of High Mobility Group Box 1-Toll Like Receptors (2/4) in Parkinson’s disease and in the MPTP mouse model of Parkinson’s disease.Matteo Santoro — 2018
• Study of an integrated non-motor symptoms questionnaire for Parkinson＇s diseaseYū, Bo Bo, Xiao — 2010
• Further Discussion on the Three Methods for the Stage-Treatment of Parkinson＇s Disease赵国华 — 2008
• Analysis on the Effect of Heavy Metals and Genetics on the Prevalence of Parkinson’s DiseaseChen‐Yu Zhang — 2020
• P2.109 Piclozotan reduces dyskinesia and OFF time in Parkinson's disease (PD) patients with L-dopa induced motor complicationsR. Hauser, Julian Gertner, Masayuki Okamoto — 2009
• Enteric nervous system (ENS) involvement in Parkinson's disease: Immunohistochemical evidence of dopamine depletion and lewy body formation in the colon of patients with Parkinson's disease (PD)Chandar Singaram, Waseem Ashraf, RF Pfeiffer — 1994